What's new in columnar lined esophagus (Barrett's metaplasia)?

Current Opinion in Gastroenterology

Volumn 24, Issue 4, 2008, Pages 516-520

  Tadiparthi, Rashmi ^a   Bansal, Ajay ^a   Sharma, Prateek ^a,b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Barrett's esophagus; Esophageal adenocarcinoma; High grade dysplasia; Novel imaging techniques

Indexed keywords

ADIPONECTIN; GHRELIN;

AUTOFLUORESCENCE IMAGING; BARRETT ESOPHAGUS; BODY MASS; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER INVASION; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CAPSULE ENDOSCOPY; CONFOCAL LASER MICROSCOPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DYSPLASIA; ENDOSCOPIC MUCOSAL RESECTION; ENDOSCOPIC THERAPY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS RESECTION; ETHNICITY; FEASIBILITY STUDY; HUMAN; METAPLASIA; NARROW BAND IMAGING; NEOPLASM; OBESITY; PHOTODYNAMIC THERAPY; PREVALENCE; RADIOFREQUENCY ABLATION; REVIEW; RISK ASSESSMENT; RISK FACTOR;

ADENOCARCINOMA; BARRETT ESOPHAGUS; ESOPHAGEAL NEOPLASMS; HUMANS; METAPLASIA; POPULATION SURVEILLANCE; RISK FACTORS;

EID: 67649802971     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e3283025c80     Document Type: Review

References (22)

1. Poh H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence.J Natl Cancer Inst 2005; 97:142-146.
2. Hamilton SR, Smith RRL, Cameron JL. Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. Hum Pathol 1988; 19:942-948.
3. Sharma P, Wani S, Rastogi A, et al.The diagnostic accuracy of esophageal capsule endoscopy in patients with gastroesophageal reflux disease and Barrett's esophagus: a blinded prospective study. Am J Gastroenterol 2008; 103:525-532.
4. Sharma P, Dent J, Armstrong D, et al. The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C&M criteria. Gastroenterology 2006; 131:1392-1399.
5. Sharma P, McQuaid K, Dent J, et al. A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago workshop. Gastroenterology 2004; 127:310-330.
6. Harrison R, Perry I, Haddadin W, et al. Detection of intestinal metaplasia in Barrett's esophagus: an observational comparator study suggests the need for a minimum of eight biopsies. Am J Gastroenterol 2007; 102:1154-1161.
7. Abrams JA, Fields S, Lightdale CJ, et al. Racial and ethnic disparities in the prevalence of Barret's esophagus among patients who undergo upper endoscopy. Clin Gastroenterol Hepatol 2008; 6:30-34.
8. Corley DA, Kubo A, Levin TR, et al. Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology 2007; 33:34-41.
9. Konturek PC, Burnat G, Rau T, et al. Effect of adiponectin and ghrelin on apoptosis of Barrett adenocarcinoma cell line. Dig Dis Sci 2008; 53:597-605.
10. Hameeteman W, Tytgat GNJ, Houthoff HJ, et al. Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 1989; 96:1249-1256.
11. Schnell TG, Sontag SJ, Chejfec G, et al. Long-term nonsurgical management of Barrett's esophagus with high grade dysplasia. Gastroenterology 2001; 120:1607-1619.
12. Rastogi A, Puli S, El-Serag HB, et al. Incidence of esophageal adenocarci- noma in patients with Barrett's esophagus and high-grade dysplasia: a metaanalysis. Gastrointest Endosc 2008; 67:394-399.
13. Clemons NJ, MCColl KE, Fitzgerald R. Nitric oxide and acid induce double- strand DNA breaks in Barrett's carcinogenesis via distinct mechanisms. Gastroenterology 2007; 133:1198-1209.
14. Siahpush SH, Vaughan T, Lampe JN, et al. Longitudinal study of insulin-like growth factor binding protein-3, and their polymorphisms: risk of neoplastic progression in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 2007; 16:2387-2395.
15. Sharma P, Bansal A, Mathur S, et al. The utility of narrow band imaging endoscopy system in patients with Barrett's esophagus. Gastrointest Endosc 2006; 64:167-175.
16. Curvers WL, Singh R, Song LM, et al. Endoscopic tri-modal imaging for detection of early neoplasia in Barrett's oesophagus: a multicentre feasibility study using high-resolution endoscopy, autofluorescence imaging and narrow band imaging incorporated in one endoscopy system. Gut 2008; 57:167-172.
17. Kiesslich R, Gossner L, Goetz M, et al. In vivo histology of Barrett's esophagus and associated neoplasia by confocal laser endomicroscopy. Clin Gastroenterol Hepatol 2006; 4:979-987.
18. Konda VJ, Ross AS, Ferguson MK, et al. Is the risk of concomitant invasive esophageal cancer in high-grade dysplasia in Barrett's esophagus overestimated? Clin Gastroenterol Hepatol 2008; 6:159-164.
19. Ell C, May A, Pech O, et al. Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer). Gastrointest Endosc 2007; 65:3-10.
20. Overholt BF, Wang KK, Burdick S, et al. Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia. Gastrointest Endosc 2007; 66:460-468.
21. Sharma VK, Wang KK, Overholt BF, et al. Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc 2007; 65:185-195.
22. Prasad GA, Wang KK, Buttar NS, et al. Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus. Gastroenterology 2007; 132:1226-1233. 23 Heath EI,CantoMI, PiantadosiS, et al. Secondary chemoprevention of Barrett's esophagus with celecoxib: results of a randomized trial. J Natl Cancer Inst 2007; 99:545-557.